Sudden Sensorineural Hearing Loss Clinical Trial
Official title:
Towards a Self-Administered Hearing Protection Regimen
A small clinical trial for idiopathic sudden sensorineural hearing loss (ISSNHL). Will the addition of an oral statin to the standard treatment (oral methylprednesolone and the salvage therapy of intratympanic dexamethasone) improve the treatment outcome for patients with ISSNHL? This study will compare the two treatments and quantitatively evaluate hearing and speech discrimination and have the patients subjectively evaluate tinnitus.
After being informed about the study and potential risks, all patients diagnosed with idopathic sudden sensorineural hearing loss who do not meet the exclusion criteria and do meet the inclusion criteria, and who give written informed consent will be enrolled in the trial. A standard treatment for ISSNHL (oral methyprednisolone) will be given to half of the patients and the other half of the patients will receive the standard treatment plus either a placebo or a 7-day course of an HMG-CoA reductase inhibitor (a statin). Patients will return for follow up, the timing and further treatment of which will be determined by the response to the drugs. At each appointment, the patients will see the medical professional, have a hearing test, a speech in noise test, and self evaluate for tinnitus. If there is no improvement after 2 weeks, patient will be offered up to two intratympanic doses of dexamethasone, 10 days apart. This is a randomized, double-blind prospective study. Randomization of males will be separate from that of females. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
| Recruiting |
NCT05403229 -
The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
|
Phase 2 | |
| Not yet recruiting |
NCT05608161 -
Speech Perception Impairment Follow Complete Recovery of Sudden Sensorineural Hearing Loss
|
||
| Recruiting |
NCT04961099 -
Phase I Clinical Study of HY01 in Patients
|
Phase 1 | |
| Recruiting |
NCT06278129 -
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
|
||
| Recruiting |
NCT06249919 -
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05849519 -
Small Sample，Unicentric，Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss
|
Early Phase 1 | |
| Not yet recruiting |
NCT04224909 -
Video HIT in Sudden Sensorineural Hearing Loss
|
||
| Not yet recruiting |
NCT06365775 -
Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
|
||
| Not yet recruiting |
NCT06355102 -
The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics
|